Showing results (961-970 of 10,663) with videos related to
Sort By:
Pageof 1,067
Metabolism: Clinical and Experimental|August 1, 1996
Molecular mechanisms of antiproliferative effect of somatostatin: involvement of a tyrosine phosphataseF Lopez, J P Estève, L Buscail, et al.Metabolism: Clinical and Experimental|August 1, 1996
Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationshipsP Grass, P Marbach, C Bruns, et al.Metabolism: Clinical and Experimental|August 1, 1996
Somatostatin receptors and their subtypes in human tumors and in peritumoral vesselsJ C Reubi, J C Schaer, J A Laissue, et al.Metabolism: Clinical and Experimental|August 1, 1996
Cardiovascular aspects in acromegaly: effects of treatmentG Lombardi, A Colao, D Ferone, et al.Metabolism: Clinical and Experimental|August 1, 1996
Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patientsI Lancranjan, C Bruns, P Grass, et al.Metabolism: Clinical and Experimental|August 1, 1996
Thyrotropin-secreting pituitary adenomasP Beck-Peccoz, L Persani, S Mantovani, et al.Metabolism: Clinical and Experimental|August 1, 1996
Is there a role for somatostatin and its analogs in Cushing's syndrome?W W de Herder, S W LambertsMetabolism: Clinical and Experimental|August 1, 1996
The relevance of somatostatin receptor expression in malignant lymphomasP J van den Anker-Lugtenburg, B Löwenberg, S W Lamberts, et al.Metabolism: Clinical and Experimental|August 1, 1996
Surgical therapy of pituitary adenomasM Giovanelli, M Losa, P MortiniMetabolism: Clinical and Experimental|August 1, 1996
Role of the new growth hormone-releasing secretagogues in the diagnosis of some hypothalamopituitary pathologiesF F Casanueva, D Micic, M Pombo, et al.Pageof 1,067